Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 5c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c